Cardiac Toxicity in Perinatally HIV-Infected Adolescents and Young Adults, a Longitudinal Study

围产期 HIV 感染青少年和年轻人的心脏毒性纵向研究

基本信息

项目摘要

Project Summary While the widespread use of highly active antiretroviral therapy has markedly decreased cardiac morbidity and mortality in perinatally HIV-infected children, several studies have suggested subclinical abnormalities in echocardiographic measures of left ventricular structure and function. The goal of this study is to longitudinally evaluate the cardiovascular status of perinatally HIV-infected adolescents and young adults and to explore whether chronic inflammation and/or mitochondrial abnormalities are associated with echocardiographic and biomarker changes over time. The specific aims of this study are to 1) to determine longitudinal changes of cardiovascular risk factors that were assessed ~6 years ago in the AMP (adolescents) and AMP Up (young adults) perinatally HIV-infected (PHIV) and HIV-exposed, uninfected (PHEU) cohorts of the Pediatric HIV/AIDS Cohort Study (PHACS); and to measure modified Pathobiological Determinants of Atherosclerosis in Youth or PDAY scores (a measure of aggregate cardiovascular risk) in HIV-infected adolescents longitudinally; and 2) To determine the role of systemic mitochondrial dysfunction in cardiovascular abnormalities and biomarkers by assaying mitochondrial DNA (mtDNA) copies/cell, oxidative phosphorylation (OXPHOS) enzyme activities, oxygen consumption (respiration), and mitochondrial oxidative stress. The results of this study can identify if there are perinatally HIV-infected adolescents and young adults, with long term exposure to HAART, which are at increased risk of future cardiovascular morbidities. If this is the case, the results of this study can inform various interventions in this increased cardiovascular risk group to decrease their future risk of adverse cardiovascular events.
项目摘要 尽管高度活性抗逆转录病毒疗法的广泛使用显着降低了心脏 几项研究表明亚临床的发病率和死亡率 左心室结构和功能的超声心动图测量值异常。这项研究的目的是 纵向评估受HIV感染的青少年和年轻人的心血管状态 并探索慢性炎症和/或线粒体异常是否与 超声心动图和生物标志物会随着时间而变化。这项研究的具体目的是1)确定 大约6年前在AMP(青少年)评估的心血管危险因素的纵向变化 和AMP UP(年轻人)受HIV感染(pHIV)和艾滋病毒暴露,未感染的(PHEU)队列 小儿艾滋病毒/艾滋病队列研究(PHACS);并测量修改的病理生物学决定因素 HIV感染的青年或PDAY评分的动脉粥样硬化(一种量度的心血管风险) 青少年纵向; 2)确定系统性线粒体功能障碍在 通过测定线粒体DNA(mtDNA)副本/细胞,氧化,心血管异常和生物标志物 磷酸化(OXPHOS)酶活性,氧气消耗(呼吸)和线粒体氧化 压力。这项研究的结果可以确定是否有围产期HIV感染的青少年和年轻人, 长期暴露于HAART,后者的风险增加了未来的心血管病。如果是 案例,这项研究的结果可以告知这种增加的心血管风险群体的各种干预措施 减少他们未来不良心血管事件的风险。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Disruption of healthcare: Will the COVID pandemic worsen non-COVID outcomes and disease outbreaks?
  • DOI:
    10.1016/j.ppedcard.2020.101254
  • 发表时间:
    2020-12-01
  • 期刊:
  • 影响因子:
    0.9
  • 作者:
    Barach, Paul;Fisher, Stacy D.;Lipshultz, Steven E.
  • 通讯作者:
    Lipshultz, Steven E.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN EDWARD LIPSHULTZ其他文献

STEVEN EDWARD LIPSHULTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN EDWARD LIPSHULTZ', 18)}}的其他基金

Prognostic Significance of microRNA Expression in Children with Cardiomyopathy
microRNA 表达在儿童心肌病中的预后意义
  • 批准号:
    9919623
  • 财政年份:
    2018
  • 资助金额:
    $ 67.24万
  • 项目类别:
Prognostic Significance of microRNA Expression in Children with Cardiomyopathy
microRNA 表达在儿童心肌病中的预后意义
  • 批准号:
    9907570
  • 财政年份:
    2018
  • 资助金额:
    $ 67.24万
  • 项目类别:
Cardiac Toxicity in Perinatally HIV-infected Adolescents and Young Adults, a Longitudinal Study
围产期 HIV 感染青少年和年轻人的心脏毒性,一项纵向研究
  • 批准号:
    9349153
  • 财政年份:
    2017
  • 资助金额:
    $ 67.24万
  • 项目类别:
Cardiac Toxicity in Perinatally HIV-Infected Adolescents and Young Adults, a Longitudinal Study
围产期 HIV 感染青少年和年轻人的心脏毒性纵向研究
  • 批准号:
    9920990
  • 财政年份:
    2017
  • 资助金额:
    $ 67.24万
  • 项目类别:
Third International Conference on Cardiomyopathy in Children
第三届国际儿童心肌病会议
  • 批准号:
    8719524
  • 财政年份:
    2014
  • 资助金额:
    $ 67.24万
  • 项目类别:
Cardiac Biomarkers in Pediatric Cardiomyopathy
小儿心肌病的心脏生物标志物
  • 批准号:
    8523196
  • 财政年份:
    2012
  • 资助金额:
    $ 67.24万
  • 项目类别:
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
小儿心肌病的基因型-表型关联
  • 批准号:
    8826164
  • 财政年份:
    2012
  • 资助金额:
    $ 67.24万
  • 项目类别:
Cardiac Biomarkers in Pediatric Cardiomyopathy
小儿心肌病的心脏生物标志物
  • 批准号:
    8295233
  • 财政年份:
    2012
  • 资助金额:
    $ 67.24万
  • 项目类别:
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
小儿心肌病的基因型-表型关联
  • 批准号:
    8452690
  • 财政年份:
    2012
  • 资助金额:
    $ 67.24万
  • 项目类别:
Genotype-Phenotype Associations in Pediatric Cardiomyopathy
小儿心肌病的基因型-表型关联
  • 批准号:
    8858884
  • 财政年份:
    2012
  • 资助金额:
    $ 67.24万
  • 项目类别:

相似海外基金

Implementation Science to Understand and Design Stakeholder Informed Innovative Interventions to Improve Adolescent and Youth HIV Prevention and Care Continuums in Rural and Urban Uganda
实施科学以理解和设计利益相关者知情的创新干预措施,以改善乌干达农村和城市青少年艾滋病毒预防和护理的连续性
  • 批准号:
    10749472
  • 财政年份:
    2023
  • 资助金额:
    $ 67.24万
  • 项目类别:
PHASE I STUDY OF PHARMACOKINETICS, SAFETY AND ACCEPTABILITY OF A SINGLE DOSE OF PRETOMANID ADDED TO AN OPTIMIZED BACKGROUND REGIMEN IN CHILDREN WITH RIFAMPICIN RESISTANT TUBERCULOSIS IMPAACT 2034
对患有利福平耐药结核病儿童的单剂量 Pretomanid 的药代动力学、安全性和可接受性的 I 期研究添加到优化背景方案中的影响 2034
  • 批准号:
    10679271
  • 财政年份:
    2022
  • 资助金额:
    $ 67.24万
  • 项目类别:
Reducing the intersecting stigmas of HIV, violence victimization, and mental health: a randomized controlled pilot integrating Project YES! Youth Engaging for Success and Problem Management Plus amon
减少艾滋病毒、暴力受害和心理健康的交叉耻辱:整合“YES!”项目的随机对照试点
  • 批准号:
    10542948
  • 财政年份:
    2022
  • 资助金额:
    $ 67.24万
  • 项目类别:
Self-Management among adolescents living with HIV in Uganda
乌干达艾滋病毒感染青少年的自我管理
  • 批准号:
    10291139
  • 财政年份:
    2021
  • 资助金额:
    $ 67.24万
  • 项目类别:
SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth
SYV:改善坦桑尼亚青年艾滋病毒感染结果的心理健康干预措施
  • 批准号:
    10160486
  • 财政年份:
    2021
  • 资助金额:
    $ 67.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了